Results 161 to 170 of about 84,994 (214)

Ventricular Volumetric Changes After Transcatheter Tricuspid Valve Replacement in a Heart Transplant Recipient. [PDF]

JACC Case Rep
Ozdemir D, Singh M, Bajwa FA, Iskandar JP, Melito EC, Kaproth-Joslin K, Hisamoto K, Chen L, Ling FS.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transcatheter left ventriculoplasty

EuroIntervention, 2023
Despite significant advances in pharmacological, electrophysiological and valve therapies for heart failure with reduced ejection fraction (HFrEF), the associated morbidity, mortality and healthcare costs remain high. With a constantly growing heart failure population, the existing treatment gap between current and advanced heart failure therapies (e.g.
Spilias, Nikolaos, Howard, Travis M., Anthony, Chris M., Laczay, Balint, Soltesz, Edward G., Starling, Randall C., Sievert, Horst, Estep, Jerry D., Kapadia, Samir R., Puri, Rishi   +9 more
openaire   +2 more sources

The selection of transcatheter heart valves in transcatheter aortic valve replacement

Trends in Cardiovascular Medicine, 2022
Transcatheter heart valve technology has rapidly progressed since initial approval in the United States. There are currently two widely available transcatheter heart valve delivery systems approved in the US; however limited data exist on optimal device selection for various patient populations.
Zachary, Tugaoen, Peter, Nguyen, Sameer, Arora, John, Vavalle   +3 more
openaire   +2 more sources

Transcatheter mitral valve repair - transcatheter mitral valve annuloplasty

EuroIntervention, 2014
Percutaneous mitral valve therapies have emerged as an alternative option for high-risk patients with mitral regurgitation. Multiple technologies and diversified approaches are today under clinical study or in development and they can be categorised based on the anatomically and pathophysiologically addressed target.
Taramasso M, Maisano F
openaire   +5 more sources